Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020)
Minerva Neurosciences (NERV) posted Change in Acquisitions & Divestments of $3.0 million for Q3 2020, down 33.33% on a QoQ basis from $4.5 million in Q2 2020, and down 91.63% year-over-year from $35.8 million in Q4 2019.
Minerva Neurosciences (NERV) Change in Acquisitions & Divestments (2015 - 2020) Analysis & Trends
Minerva Neurosciences' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $3.0 million for Q3 2020.
- Quarterly Change in Acquisitions & Divestments fell 91.63% year-over-year to $3.0 million in Q3 2020, while the trailing twelve-month figure through Dec 2020 was $28.4 million (down 62.22% YoY) and the FY2020 annual result came in at $28.4 million, down 62.22% from the prior year.
- Change in Acquisitions & Divestments was $3.0 million for Q3 2020 at Minerva Neurosciences, down from $4.5 million in the prior quarter.
- Across five years, Change in Acquisitions & Divestments topped out at $39.2 million in Q1 2018 and bottomed at $1.4 million in Q2 2016.
- A 4-year average of $16.5 million and a median of $9.2 million in 2019 frame the typical range for Change in Acquisitions & Divestments.
- Peak annual rise in Change in Acquisitions & Divestments reached 132.22% in 2020, while the deepest fall reached 91.63% in 2020.
- Minerva Neurosciences' Change in Acquisitions & Divestments stood at $8.4 million in 2016, then tumbled by 36.72% to $5.3 million in 2018, then surged by 76.11% to $9.3 million in 2019, then tumbled by 67.86% to $3.0 million in 2020.
- Business Quant data shows NERV's Change in Acquisitions & Divestments at $3.0 million in Q3 2020, $4.5 million in Q2 2020, and $20.9 million in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,042.03 Bn | 67,041.74 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.62 Bn | 466.83 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.97 Bn | 114.72 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.75 Bn | 50.57 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Minerva Neurosciences | 183.94 Mn | 183.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | 3.00 Mn |
| Sep 30, 2020 | 3.00 Mn |
| Jun 30, 2020 | 4.50 Mn |
| Jun 30, 2020 | 4.50 Mn |
| Mar 31, 2020 | 20.90 Mn |
| Mar 31, 2020 | 20.90 Mn |
| Dec 31, 2019 | 9.33 Mn |
| Dec 31, 2019 | 9.33 Mn |
| Sep 30, 2019 | 35.85 Mn |
| Sep 30, 2019 | 35.85 Mn |
| Jun 30, 2019 | 21.00 Mn |
| Jun 30, 2019 | 21.00 Mn |
| Mar 31, 2019 | 9.00 Mn |
| Mar 31, 2019 | 9.00 Mn |
| Dec 31, 2018 | 5.30 Mn |
| Dec 31, 2018 | 5.30 Mn |
| Sep 30, 2018 | 29.50 Mn |
| Sep 30, 2018 | 29.50 Mn |
| Jun 30, 2018 | 36.10 Mn |
| Jun 30, 2018 | 36.10 Mn |